BridgeBio Pharma Inc (NASDAQ:BBIO)

9.92
Delayed Data
As of Jul 01
 +0.84 / +9.25%
Today’s Change
4.98
Today|||52-Week Range
65.33
-40.53%
Year-to-Date

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for BridgeBio Pharma Inc have a median target of 23.50, with a high estimate of 32.00 and a low estimate of 13.00. The median estimate represents a +136.90% increase from the last price of 9.92.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in BridgeBio Pharma Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.60
Sales
$41.9M
Reporting Date
Aug 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 55.27%
 
 
 
 
 
 
Growthannually 7.99%
 
 
 
 
 

Sales

Growthquarterly 2,374.44%
 
 
 
 
 
 
Growthannually 22.84%
 
 
 
 
 
Key to the earnings and sales forecast charts.